Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators.

Yohn SE, Foster DJ, Covey DP, Moehle MS, Galbraith J, Garcia-Barrantes PM, Cho HP, Bubser M, Blobaum AL, Joffe ME, Cheer JF, Jones CK, Lindsley CW, Conn PJ.

Mol Psychiatry. 2018 Aug 16. doi: 10.1038/s41380-018-0206-2. [Epub ahead of print]

PMID:
30116027
2.

Cannabinoid receptor-1 signaling contributions to sign-tracking and conditioned reinforcement in rats.

Bacharach SZ, Nasser HM, Zlebnik NE, Dantrassy HM, Kochli DE, Gyawali U, Cheer JF, Calu DJ.

Psychopharmacology (Berl). 2018 Aug 14. doi: 10.1007/s00213-018-4993-6. [Epub ahead of print]

PMID:
30109373
3.

Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Covey DP, Dantrassy HM, Yohn SE, Castro A, Conn PJ, Mateo Y, Cheer JF.

Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. [Epub ahead of print]

PMID:
29925886
4.

Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the Midbrain.

Wenzel JM, Oleson EB, Gove WN, Cole AB, Gyawali U, Dantrassy HM, Bluett RJ, Dryanovski DI, Stuber GD, Deisseroth K, Mathur BN, Patel S, Lupica CR, Cheer JF.

Curr Biol. 2018 May 7;28(9):1392-1404.e5. doi: 10.1016/j.cub.2018.03.037. Epub 2018 Apr 19.

PMID:
29681476
5.

An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.

Bailey MR, Goldman O, Bello EP, Chohan MO, Jeong N, Winiger V, Chun E, Schipani E, Kalmbach A, Cheer JF, Balsam PD, Simpson EH.

J Neurosci. 2018 Feb 28;38(9):2149-2162. doi: 10.1523/JNEUROSCI.2088-17.2018. Epub 2018 Jan 24.

PMID:
29367407
6.

Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Mateo Y, Johnson KA, Covey DP, Atwood BK, Wang HL, Zhang S, Gildish I, Cachope R, Bellocchio L, Guzmán M, Morales M, Cheer JF, Lovinger DM.

Neuron. 2017 Dec 6;96(5):1112-1126.e5. doi: 10.1016/j.neuron.2017.11.012.

PMID:
29216450
7.

A new dawn in cannabinoid neurobiology: The road from molecules to therapeutic discoveries.

Cheer JF, Hurd YL.

Neuropharmacology. 2017 Sep 15;124:1-2. doi: 10.1016/j.neuropharm.2017.07.004. Epub 2017 Jul 8. No abstract available.

PMID:
28694099
8.

Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling.

Wenzel JM, Cheer JF.

Neuropsychopharmacology. 2018 Jan;43(1):103-115. doi: 10.1038/npp.2017.126. Epub 2017 Jun 27. Review.

PMID:
28653666
9.

Ensembles in medial and lateral orbitofrontal cortex construct cognitive maps emphasizing different features of the behavioral landscape.

Lopatina N, Sadacca BF, McDannald MA, Styer CV, Peterson JF, Cheer JF, Schoenbaum G.

Behav Neurosci. 2017 Jun;131(3):201-12. doi: 10.1037/bne0000195.

10.

Endocannabinoid modulation of dopamine neurotransmission.

Covey DP, Mateo Y, Sulzer D, Cheer JF, Lovinger DM.

Neuropharmacology. 2017 Sep 15;124:52-61. doi: 10.1016/j.neuropharm.2017.04.033. Epub 2017 Apr 25. Review.

PMID:
28450060
11.

The endocannabinoid system as a target for novel anxiolytic drugs.

Patel S, Hill MN, Cheer JF, Wotjak CT, Holmes A.

Neurosci Biobehav Rev. 2017 May;76(Pt A):56-66. doi: 10.1016/j.neubiorev.2016.12.033. Review.

12.

Reduced levels of Cacna1c attenuate mesolimbic dopamine system function.

Terrillion CE, Dao DT, Cachope R, Lobo MK, Puche AC, Cheer JF, Gould TD.

Genes Brain Behav. 2017 Jun;16(5):495-505. doi: 10.1111/gbb.12371. Epub 2017 Mar 13.

13.

Subsecond Sensory Modulation of Serotonin Levels in a Primary Sensory Area and Its Relation to Ongoing Communication Behavior in a Weakly Electric Fish.

Fotowat H, Harvey-Girard E, Cheer JF, Krahe R, Maler L.

eNeuro. 2016 Nov 2;3(5). pii: ENEURO.0115-16.2016. eCollection 2016 Sep-Oct.

14.

Chronic lithium treatment rectifies maladaptive dopamine release in the nucleus accumbens.

Can A, Frost DO, Cachope R, Cheer JF, Gould TD.

J Neurochem. 2016 Nov;139(4):576-585. doi: 10.1111/jnc.13769. Epub 2016 Oct 18.

15.

Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Zlebnik NE, Cheer JF.

J Neurosci. 2016 Oct 5;36(40):10230-10238. Review.

16.

Medial Orbitofrontal Neurons Preferentially Signal Cues Predicting Changes in Reward during Unblocking.

Lopatina N, McDannald MA, Styer CV, Peterson JF, Sadacca BF, Cheer JF, Schoenbaum G.

J Neurosci. 2016 Aug 10;36(32):8416-24. doi: 10.1523/JNEUROSCI.1101-16.2016.

17.

Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

Can A, Zanos P, Moaddel R, Kang HJ, Dossou KS, Wainer IW, Cheer JF, Frost DO, Huang XP, Gould TD.

J Pharmacol Exp Ther. 2016 Oct;359(1):159-70. doi: 10.1124/jpet.116.235838. Epub 2016 Jul 28.

18.

Subsecond Regulation of Synaptically Released Dopamine by COMT in the Olfactory Bulb.

Cockerham R, Liu S, Cachope R, Kiyokage E, Cheer JF, Shipley MT, Puche AC.

J Neurosci. 2016 Jul 20;36(29):7779-85. doi: 10.1523/JNEUROSCI.0658-16.2016.

19.

Endocannabinoid Regulation of Cocaine Reinforcement: an Upper or Downer?

Covey DP, Zlebnik NE, Cheer JF.

Neuropsychopharmacology. 2016 Aug;41(9):2189-91. doi: 10.1038/npp.2016.25. No abstract available.

20.
21.

Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.

Covey DP, Bunner KD, Schuweiler DR, Cheer JF, Garris PA.

Eur J Neurosci. 2016 Jun;43(12):1661-73. doi: 10.1111/ejn.13248. Epub 2016 May 11.

22.

Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

Zlebnik NE, Cheer JF.

Annu Rev Neurosci. 2016 Jul 8;39:1-17. doi: 10.1146/annurev-neuro-070815-014038. Epub 2016 Feb 24. Review.

23.

To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making.

Hernandez G, Cheer JF.

Front Behav Neurosci. 2015 Dec 17;9:336. doi: 10.3389/fnbeh.2015.00336. eCollection 2015. Review.

24.

Lateral orbitofrontal neurons acquire responses to upshifted, downshifted, or blocked cues during unblocking.

Lopatina N, McDannald MA, Styer CV, Sadacca BF, Cheer JF, Schoenbaum G.

Elife. 2015 Dec 15;4:e11299. doi: 10.7554/eLife.11299.

25.

Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area.

Wang H, Treadway T, Covey DP, Cheer JF, Lupica CR.

Cell Rep. 2015 Sep 29;12(12):1997-2008. doi: 10.1016/j.celrep.2015.08.041. Epub 2015 Sep 10.

26.

Corrigendum: Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression.

Bagot RC, Parise EM, Peña CJ, Zhang HX, Maze I, Chaudhury D, Persaud B, Cachope R, Bolaños-Guzmán CA, Cheer JF, Deisseroth K, Han MH, Nestler EJ.

Nat Commun. 2015 Jun 17;6:7626. doi: 10.1038/ncomms8626. No abstract available.

27.

Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression.

Bagot RC, Parise EM, Peña CJ, Zhang HX, Maze I, Chaudhury D, Persaud B, Cachope R, Bolaños-Guzmán CA, Cheer JF, Deisseroth K, Han MH, Nestler EJ.

Nat Commun. 2015 May 8;6:7062. doi: 10.1038/ncomms8062. Erratum in: Nat Commun. 2015;6:7626. Cheer, Joseph [Corrected to Cheer, Joseph F].

28.

A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Wenzel JM, Rauscher NA, Cheer JF, Oleson EB.

ACS Chem Neurosci. 2015 Jan 21;6(1):16-26. doi: 10.1021/cn500255p. Epub 2014 Dec 24. Review.

29.

Cannabinoid modulation of drug reward and the implications of marijuana legalization.

Covey DP, Wenzel JM, Cheer JF.

Brain Res. 2015 Dec 2;1628(Pt A):233-43. doi: 10.1016/j.brainres.2014.11.034. Epub 2014 Nov 25. Review.

30.

Observation of reward delivery to a conspecific modulates dopamine release in ventral striatum.

Kashtelyan V, Lichtenberg NT, Chen ML, Cheer JF, Roesch MR.

Curr Biol. 2014 Nov 3;24(21):2564-8. doi: 10.1016/j.cub.2014.09.016. Epub 2014 Oct 23.

31.

Pick your poison: not all opioids are created equal in the eyes of dopamine (commentary on Vander Weele et al.).

Covey DP, Cheer JF.

Eur J Neurosci. 2014 Oct;40(7):3040. doi: 10.1111/ejn.12726. No abstract available.

32.

Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues.

Wenzel JM, Cheer JF.

Front Psychiatry. 2014 Sep 1;5:118. doi: 10.3389/fpsyt.2014.00118. eCollection 2014. Review.

33.

Real-time dopamine measurement in awake monkeys.

Schluter EW, Mitz AR, Cheer JF, Averbeck BB.

PLoS One. 2014 Jun 12;9(6):e98692. doi: 10.1371/journal.pone.0098692. eCollection 2014.

34.

Local control of striatal dopamine release.

Cachope R, Cheer JF.

Front Behav Neurosci. 2014 May 23;8:188. doi: 10.3389/fnbeh.2014.00188. eCollection 2014. Review.

35.

Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release.

Oleson EB, Cachope R, Fitoussi A, Tsutsui K, Wu S, Gallegos JA, Cheer JF.

Neuropsychopharmacology. 2014 May;39(6):1441-52. doi: 10.1038/npp.2013.340. Epub 2013 Dec 18.

36.

ΔFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli.

Lobo MK, Zaman S, Damez-Werno DM, Koo JW, Bagot RC, DiNieri JA, Nugent A, Finkel E, Chaudhury D, Chandra R, Riberio E, Rabkin J, Mouzon E, Cachope R, Cheer JF, Han MH, Dietz DM, Self DW, Hurd YL, Vialou V, Nestler EJ.

J Neurosci. 2013 Nov 20;33(47):18381-95. doi: 10.1523/JNEUROSCI.1875-13.2013.

37.

Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates.

Hernandez G, Oleson EB, Gentry RN, Abbas Z, Bernstein DL, Arvanitogiannis A, Cheer JF.

Biol Psychiatry. 2014 Mar 15;75(6):487-98. doi: 10.1016/j.biopsych.2013.09.005. Epub 2013 Oct 17.

38.

Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone?

Oleson EB, Cachope R, Fitoussi A, Cheer JF.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:17-23. doi: 10.1016/j.pnpbp.2013.07.019. Epub 2013 Aug 1. Review.

39.

On the role of subsecond dopamine release in conditioned avoidance.

Oleson EB, Cheer JF.

Front Neurosci. 2013 Jun 7;7:96. doi: 10.3389/fnins.2013.00096. eCollection 2013.

40.

Optogenetic inhibition of D1R containing nucleus accumbens neurons alters cocaine-mediated regulation of Tiam1.

Chandra R, Lenz JD, Gancarz AM, Chaudhury D, Schroeder GL, Han MH, Cheer JF, Dietz DM, Lobo MK.

Front Mol Neurosci. 2013 May 24;6:13. doi: 10.3389/fnmol.2013.00013. eCollection 2013.

41.

Conditioned contribution of peripheral cocaine actions to cocaine reward and cocaine-seeking.

Wang B, You ZB, Oleson EB, Cheer JF, Myal S, Wise RA.

Neuropsychopharmacology. 2013 Aug;38(9):1763-9. doi: 10.1038/npp.2013.75. Epub 2013 Mar 27.

42.

Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function.

Vinish M, Elnabawi A, Milstein JA, Burke JS, Kallevang JK, Turek KC, Lansink CS, Merchenthaler I, Bailey AM, Kolb B, Cheer JF, Frost DO.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1599-609. doi: 10.1017/S1461145712001642. Epub 2013 Jan 25.

43.

Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Lee AM, Oleson EB, Diergaarde L, Cheer JF, Pattij T.

Basal Ganglia. 2012 Sep 1;2(3):131-138. Epub 2012 Jul 28.

44.

Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance.

Oleson EB, Gentry RN, Chioma VC, Cheer JF.

J Neurosci. 2012 Oct 17;32(42):14804-8. doi: 10.1523/JNEUROSCI.3087-12.2012.

45.

Using dopamine research to generate rational cannabinoid drug policy.

Loewinger GC, Oleson EB, Cheer JF.

Drug Test Anal. 2013 Jan;5(1):22-6. doi: 10.1002/dta.1410. Epub 2012 Sep 19.

46.

A brain on cannabinoids: the role of dopamine release in reward seeking.

Oleson EB, Cheer JF.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a012229. doi: 10.1101/cshperspect.a012229. Review.

47.

Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.

Hernandez G, Cheer JF.

J Neurosci. 2012 Aug 15;32(33):11467-77. doi: 10.1523/JNEUROSCI.1833-12.2012.

48.

Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing.

Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF.

Cell Rep. 2012 Jul 26;2(1):33-41. doi: 10.1016/j.celrep.2012.05.011. Epub 2012 Jul 11.

49.

Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.

Oleson EB, Cheer JF.

Synapse. 2012 Nov;66(11):984-8. doi: 10.1002/syn.21587. Epub 2012 Jul 27.

50.

Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens.

Morra JT, Glick SD, Cheer JF.

Neuropharmacology. 2012 Sep;63(4):565-74. doi: 10.1016/j.neuropharm.2012.04.036. Epub 2012 May 15.

Supplemental Content

Loading ...
Support Center